评估冠状病毒疾病 (COVID-19) 治疗方案使用炎症标记物的有效性
Naida Omerovic1, Tamer Bego1, Besim Prnjavorac1
1Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
概括
免疫调节剂,特别是甲基prednisolone和dexamethasone,有效地降低了COVID-19患者的炎症标志物. 治疗选择和患者的并发病影响了结果,强调了针对冠状病毒-19疾病的个性化治疗的重要性.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 临床医学 临床医学
背景情况:
- 冠状病毒疾病-19 (COVID-19) 呈现出复杂的病理生理学和各种各样的临床表现.
- 了解免疫调节剂对炎症标记物的影响对于有效的COVID-19治疗至关重要.
研究的目的:
- 评估免疫调节剂疗法在治疗COVID-19患者中的有效性.
- 评估疾病严重程度和并发症对炎症标志物 (ESR和CRP) 的影响.
主要方法:
- 一项涉及200名COVID-19患者 (轻度,中度,严重) 的研究.
- 监测红细胞沉积率 (ESR) 和C反应蛋白 (CRP) 水平.
- 在医院和医院后使用免疫调节剂 (皮质类固醇,托西利祖马布) 的分析.
主要成果:
- 皮质类固醇治疗显著降低了炎症标志物,特别是在严重的病例中.
- 甲基prednisolone + 德克萨米他显示出最大的效果大小.
- 高血压是最常见的并发症;并发症的数量没有显著影响ESR/CRP,但与严重程度相关.
结论:
- 免疫调节剂,特别是甲基prednisolone + dexamethasone 和医院后的甲基prednisolone,对于COVID-19治疗是合理的.
- 在COVID-19病理生理学,免疫反应和患者的并发症之间存在显著的相关性.
更多相关视频
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
11.6K
06:29Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
26.4K
相关概念视频
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137